Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.57 |
| ▸ | FOLR1 | P15328 | 6/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | HRH2 | P25021 | 4/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20045200 | 1.00 | FOLH1 (0.57) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL16088183 | 0.97 | FOLH1 (0.60) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL16075115 | 0.96 | FOLR1 (0.55) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL17774123 | 0.95 | FOLH1 (0.56) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL18771178 | 0.94 | FOLH1 (0.57) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL25489686 | 0.94 | FOLH1 (0.60) | FOLH1FOLR1PTPN1HTR1ACHRM2 | |
| SCHEMBL18608750 | 0.93 | FOLH1 (0.56) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL16597116 | 0.93 | FOLH1 (0.58) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL21905429 | 0.93 | FOLH1 (0.58) | FOLH1FOLR1PTPN1HTR1AMMP2 | |
| SCHEMBL21905423 | 0.93 | FOLH1 (0.58) | FOLH1FOLR1PTPN1HTR1AMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160106869-A1 | FLUORESCENT SOLID LIPID NANOPARTICLES COMPOSITION AND PREPARATION THEREOF | BRACCO IMAGING S.P.A. (IT) | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106869-A1 | FLUORESCENT SOLID LIPID NANOPARTICLES COMPOSITION AND PREPARATION THEREOF | LIPA, PLIN3, NPC1L1 | FOLH1 3183/4885FOLR1 1461/4885PTPN1 2005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.